📰 Primary Hyperoxaluria Type News
Primary Hyperoxaluria Type News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Primary Hyperoxaluria Type. Real-time updates on events, politics, business and more.
October 2, 2023
/PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved RivflozaTM (nedosiran) injection 80 mg, 128 mg, or...
May 5, 2023
Lucy Skinner is the first-ever Make-A-Wish Kid who will be walking in Denver Fashion Week on Sunday, May 7.
April 20, 2023
The Global Fuchs Endothelial Corneal Dystrophy Market Size was valued at USD 170 Billion in 2022 and the Worldwide Fuchs Endothelial Corneal Dystrophy...
April 17, 2023
More research from the National Kidney Foundation Spring Clinical Meeting
October 7, 2022
- OXLUMO Now Indicated for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary and Plasma Oxalate Levels in Pediatric and Adult Patie
May 9, 2022
Precision BioSciences Reports First Quarter 2022 Financial Results and Provides Business Update - read this article along with other careers information, tips and advice on BioSpace
May 3, 2022
- Accepted abstracts to be presented as oral presentations and posters highlight preclinical development progress for ARCUS® gene editing therapiesDURHAM, N.C.--(BUSINESS WIRE)--$DTIL #ARCUS--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic...
February 2, 2022
The Early Access to Medicines Scheme (EAMS) is a vitally important scheme that gives patients with life-threatening or seriously debilitating
February 2, 2022
Significant clarification of the life-changing EAMS scheme to be introduced into law.